Su JY, Lin LP, Huang ZH, Pan LX, et al. Adjuvant Immunotherapy for Hepatocellular Carcinoma: Precision Selection of the Optimal Beneficiary Population as the Core Strategy. J Hepatol 2026 Feb 15:S0168-8278(26)00075-9. doi: 10.1016/j.jhep.2026.
PMID: 41702500